blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2515856

EP2515856 - Aerosol Formulation for COPD [Right-click to bookmark this link]
Former [2012/44]AEROSOL FORMULATION FOR COPD
[2013/26]
StatusNo opposition filed within time limit
Status updated on  06.02.2015
Database last updated on 03.10.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Chiesi Farmaceutici S.p.A.
Via Palermo, 26/A
43100 Parma / IT
[2012/44]
Inventor(s)01 / BONELLI, Sauro
Chiesi FarmaceuticI S.P.A.
Via Palermo 26/A
I-43100 Parma / IT
02 / USBERTI, Francesca
Chiesi Farmaceutici S.P.A.
Via Palermo 26/A
I-43100 Parma / IT
03 / ZAMBELLI, Enrico
Chiesi Farmaceutici S.P.A.
Via Palermo 26/A
I-43100 Parma / IT
 [2012/44]
Former [2011/33]01 / BONELLI, Sauro
Chiesi FarmaceuticI S.P.A. Via Palermo 26/A
I-43100 Parma / IT
02 / USBERTI, Francesca
Chiesi Farmaceutici S.P.A. Via Palermo 26/A
I-43100 Parma / IT
03 / ZAMBELLI, Enrico
Chiesi Farmaceutici S.P.A. Via Palermo 26/A
I-43100 Parma / IT
Representative(s)Minoja, Fabrizio
Bianchetti & Minoja S.r.l.
Via Plinio, 63
20129 Milano / IT
[N/P]
Former [2012/44]Minoja, Fabrizio
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano / IT
Application number, filing date10800932.522.12.2010
WO2010EP70476
Priority number, dateEP2009018066223.12.2009         Original published format: EP 09180662
[2011/33]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011076840
Date:30.06.2011
Language:EN
[2011/26]
Type: A2 Application without search report 
No.:EP2515856
Date:31.10.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 30.06.2011 takes the place of the publication of the European patent application.
[2012/44]
Type: B1 Patent specification 
No.:EP2515856
Date:02.04.2014
Language:EN
[2014/14]
Search report(s)International search report - published on:EP01.12.2011
ClassificationIPC:A61K9/12, A61P11/06, A61P11/00, A61K45/06, A61K9/00, A61K31/40
[2013/48]
CPC:
A61K31/40 (EP,KR,US); A61K9/12 (KR); A61K45/06 (EP,US);
A61K47/10 (KR,US); A61K9/008 (EP,KR,US); A61P11/00 (EP);
A61P11/06 (EP); A61P11/08 (EP); B65B3/00 (KR,US);
B65B7/16 (KR,US) (-)
C-Set:
A61K31/40, A61K2300/00 (EP,US)
Former IPC [2013/26]A61K45/06, A61K31/40, A61K9/12, A61P11/06, A61P11/00
Former IPC [2011/33]A61K9/00, A61K31/40
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/44]
Extension statesBA18.06.2012
ME18.06.2012
TitleGerman:Aerosol-Formulierung für COPD[2013/26]
English:Aerosol Formulation for COPD[2013/26]
French:Formule d'aérosol pour COPD[2012/44]
Former [2012/44]AEROSOLFORMULIERUNG FÜR COPD
Former [2012/44]AEROSOL FORMULATION FOR COPD
Entry into regional phase18.06.2012National basic fee paid 
18.06.2012Designation fee(s) paid 
18.06.2012Examination fee paid 
Examination procedure18.06.2012Examination requested  [2012/44]
21.02.2013Amendment by applicant (claims and/or description)
19.06.2013Communication of intention to grant the patent
09.10.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.11.2013Communication of intention to grant the patent
25.11.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
20.12.2013Communication of intention to grant the patent
10.02.2014Fee for grant paid
10.02.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.06.2013
Opposition(s)06.01.2015No opposition filed within time limit [2015/11]
Fees paidRenewal fee
26.12.2012Renewal fee patent year 03
27.12.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU22.12.2010
AL02.04.2014
CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
MC02.04.2014
MK02.04.2014
MT02.04.2014
PL02.04.2014
RO02.04.2014
SE02.04.2014
SI02.04.2014
SK02.04.2014
SM02.04.2014
TR02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
RS19.11.2014
LU22.12.2014
[2018/46]
Former [2018/30]HU22.12.2010
CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
MC02.04.2014
MK02.04.2014
MT02.04.2014
PL02.04.2014
RO02.04.2014
SE02.04.2014
SI02.04.2014
SK02.04.2014
SM02.04.2014
TR02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
RS19.11.2014
LU22.12.2014
Former [2016/33]HU22.12.2010
CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
MC02.04.2014
MT02.04.2014
PL02.04.2014
RO02.04.2014
SE02.04.2014
SI02.04.2014
SK02.04.2014
SM02.04.2014
TR02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
RS19.11.2014
LU22.12.2014
Former [2016/32]HU22.12.2010
CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
MC02.04.2014
PL02.04.2014
RO02.04.2014
SE02.04.2014
SI02.04.2014
SK02.04.2014
SM02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
RS19.11.2014
LU22.12.2014
Former [2016/27]CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
MC02.04.2014
PL02.04.2014
RO02.04.2014
SE02.04.2014
SI02.04.2014
SK02.04.2014
SM02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
RS19.11.2014
LU22.12.2014
Former [2016/22]CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
RO02.04.2014
SE02.04.2014
SI02.04.2014
SK02.04.2014
SM02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
RS19.11.2014
LU22.12.2014
Former [2015/36]CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
RO02.04.2014
SE02.04.2014
SI02.04.2014
SK02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
RS19.11.2014
LU22.12.2014
Former [2015/35]CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
RO02.04.2014
SE02.04.2014
SK02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
RS19.11.2014
LU22.12.2014
Former [2015/24]CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
RO02.04.2014
SE02.04.2014
SK02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
RS19.11.2014
Former [2015/11]CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
RO02.04.2014
RS02.04.2014
SE02.04.2014
SK02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
Former [2015/10]CY02.04.2014
CZ02.04.2014
DK02.04.2014
EE02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
RS02.04.2014
SE02.04.2014
SK02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
Former [2015/08]CY02.04.2014
CZ02.04.2014
DK02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
RS02.04.2014
SE02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
Former [2015/02]CY02.04.2014
CZ02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
RS02.04.2014
SE02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
PT04.08.2014
Former [2014/52]CY02.04.2014
CZ02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
RS02.04.2014
SE02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
Former [2014/50]CY02.04.2014
CZ02.04.2014
FI02.04.2014
HR02.04.2014
LT02.04.2014
LV02.04.2014
PL02.04.2014
SE02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
Former [2014/49]CY02.04.2014
CZ02.04.2014
FI02.04.2014
LT02.04.2014
BG02.07.2014
NO02.07.2014
IS02.08.2014
Former [2014/48]CY02.04.2014
CZ02.04.2014
LT02.04.2014
BG02.07.2014
Former [2014/47]CY02.04.2014
Cited inInternational search[Y]US2004101483  (MULLER-WALZ RUDI [DE], et al) [Y] 1-12 * example 4; claims 1-52 *;
 [Y]WO2008000482  (NOVARTIS AG [CH], et al) [Y] 1-12 * page 9, paragraph 3 - page 10, paragraph 4; claims 1-17 *;
 [Y]WO2005074900  (SOFOTEC GMBH & CO KG [DE], et al) [Y] 1-12 * page 3, paragraph 3; example 2; claims 1-23 *;
 [Y]US2006257324  (LEWIS DAVID A [IT], et al) [Y] 1-12 * paragraphs [0044] , [0111]; examples 1-7; claims 1-26 *
 [Y]  - "Glycopyrronium Bromide", Martindale The complete drug reference, Pharmaceutical Press, (20020101), vol. 33, pages 467 - 467, ISBN 0853694990, XP002579323 [Y] 1-12 * the whole document *
by applicantWO2005107873
 WO0176575
 WO2006100453
 WO03053501
 WO0149350
    - HANSEL ET AL., CHEST, (2005), vol. 128, pages 1974 - 1979
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.